Design, synthesis, and biological evaluation of 1,6-naphthyridine-2-one derivatives as novel FGFR4 inhibitors for the treatment of colorectal cancer

Bo Fang, Yinshuang Lai, Hao Yan, Yue Ma, Zefeng Ni, Qianqian Zhu, Jianxia Zhang, Yanfei Ye, Mengying Wang, Peipei Wang, Yan Wang, Shuyuan Zhang, Min Hui, Dalong Wang, Yunjie Zhao, Xiaokun Li, Kun Wang, Zhiguo Liu, Yunjie Zhao, Xiaokun Li, Kun Wang, Zhiguo Liu